Paolo Falcucci
Via Elio Chianesi 55
Rome, 00144, Italy
Rome, 00144, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim.
Journal: Annals of hematology
Published: November 17, 2023
Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects.
Journal: Frontiers in immunology
Published: May 12, 2023
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience.
Journal: Frontiers in oncology
Published: March 16, 2022
The 12-week kinetics of anti-SARS-CoV-2 antibodies in different haematological cancers after vaccination with BNT162b2.
Journal: British journal of haematology
Published: September 07, 2021
Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia.
Journal: Journal of hematology & oncology
Published: May 18, 2021
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.
Journal: The New England journal of medicine
Published: May 12, 2021
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution.
Journal: Journal of hematology & oncology
Published: April 17, 2021
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region.
Journal: Frontiers in oncology
Published: January 31, 2020
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12.
Journal: Cancers
Published: May 30, 2019
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia.
Journal: Hematological oncology
Published: August 29, 2017
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome.
Journal: Annals of hematology
Published: October 09, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026